Human Papillomavirus (HPV) Literature

Amiling R, Meites E, Querec TD, et al. Juvenile-onset recurrent respiratory papillomatosis in the United States, epidemiology and HPV types—2015-2020. J Pediatr Infect Dis Soc 2021 (published online Jun 19)

Baandrup L, Dehlendorff C, Kjaer SK. One-dose human papillomavirus vaccination and the risk of genital warts: a Danish nationwide population-based study. Clin Infect Dis 2020 (published online Oct 13)

Baussano I, Tenet V, Gheit T, et al. Impact of human papillomavirus vaccination, Rwanda and Bhutan. Emerg Infect Dis 2021 Jan;27(1)

Berenson AB, Hirth JM, Chang M. Prevalence of genital human papillomavirus by age and race/ethnicity among males. Clin Infect Dis 2021 (published online May 13)

Berenson AB, Hirth JM, Chang M. Prevalence of oral human papillomavirus infection: impact of sex, race/ethnicity and vaccination status. Clin Infect Dis 2021 (published online Jul 4)

Bettampadi D, Sirak BA, Abrahamsen ME, et al. Factors associated with persistence and clearance of high-risk oral HPV among participants in the HPV Infection in Men (HIM) study. Clin Infect Dis 2020 (published online Nov 11)

Bonaldo G, Montanaro N, Vaccheri A, et al. Human papilloma virus vaccination in males: a pharmacovigilance study on the Vaccine Adverse Event Reporting System. Br J Clin Pharmacol 2020 (published online Nov 3)

Brown DR, Joura EA, Yen GP, et al. Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence. Vaccine 2021 (published online Mar 18)

Bukowinski AT, Hall C, Chang RN, et al. Maternal and infant outcomes following exposure to quadrivalent human papillomavirus vaccine during pregnancy. Vaccine 2020 (published online Jul 22)

Carnalla M, Torres-Ibarra L, Barrientos-Gutierrez T, et al. Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes. Vaccine 2021 (published online Jun 25)

Chen MM, Mott N, Clark SJ, et al. HPV vaccination among young adults in the US. JAMA (Research letter) 2021 Apr 27;325(16):1673-4

Chen ST, Huybrechts KF, Bateman BT, et al. Trends in human papillomavirus vaccination in commercially insured children in the United States. Pediatrics 2020 Sep 1;146(3)

Chesson HW, Meites E, Ekwueme DU, et al. Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: estimates from a simplified transmission model. Vaccine 2020 (published online Oct 27)

Chido-Amajuouyi OG, Talluri R, Wonodi C, et al. Trends in HPV vaccination initiation and completion within ages 9–12 years: 2008-2018. Pediatrics 2021 May:e2020012765

Chido-Amajuoyi OG, Talluri R, Shete SS, et al. Safety concerns or adverse effects as the main reason for human papillomavirus vaccine refusal: National Immunization Survey–Teen, 2008 to 2019. JAMA Pediatr (Research letter) 2021 (published online Jun 28)

Chow EP, Tabrizi  SN, Fairley CK, et al. Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study. Lancet Infect Dis 2021 (published online May 24)

Closson K, Karim ME, Sadarangani M, et al. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: a population survey-based cross-sectional analysis. Vaccine 2020 (published online Nov 22)

Closson K, Karim ME, Sadarangani M, et al. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: a population survey-based cross-sectional analysis. Vaccine 2020 (published online Nov 22)

Cornall AM, Saville M, Pyman J, et al. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination. Vaccine 2020 (published online Jul 28)

Coster J, Patel R, Delclos G, et al. Concurrent and concordant oral and genital high-risk human papillomavirus in the U.S.: results from the national Health and Nutrition Examination Survey. J Infect Dis 2020 (published online Aug 17)

Dang JH, Stewart SL, Blumberg DA, et al. Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network. Vaccine 2021 (published online May 19)

Daniels V, Saxena K, Roberts C, et al. Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: a model based analysis. Vaccine 2021 (published online Apr 6)

Denecke A, Iftner T, Iftner A, et al. Significant decline of HPV 6 infection and genital warts despite low HPV vaccination coverage in young women in Germany: a long-term prospective, cohort data analysis. BMC Infect Dis 2021 (published online Jul 2)

Do EK, Rossi B, Miller CA, et al. Area-level variation and human papillomavirus vaccination among adolescents and young adults in the United States: a systematic review. Cancer Epidemiol Biomarkers Prev 2021 Jan

Drolet M, Laprise JF, Martin D, et al. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. Lancet Infect Dis 2021 (published online Jul 7)

Giuliano AR, Niccolai LM, eds. From science to action to impact: eliminating cervical cancer. Prev Med (entire issue) Mar;144

Gray P, Kann H, Pimenoff VN, et al. Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: a cross-sectional cohort analysis following a cluster randomized trial. PLOS Med 2021 (published online Jun 7)

Grewal R, Deeks SL, Hart TA, et al. Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019. Vaccine 2021 Jun 23;39(28):3756-66

Hoes J, King AJ, Schurink–van't Klooster TM, Berkhof J, et al. Vaccine effectiveness following routine immunization with bivalent HPV vaccine: protection against incident genital HPV infections from a reduced-dosing schedule. J Infect Dis 2021 (published online May 8)

Hoes J, Woestenberg PJ, Bongaards JA, et al. Population impact of girls-only HPV16/18 vaccination in the Netherlands: cross-protective and second-order herd effects. Clin Infect Dis 2020 (published online Nov 28)

Hviid A, Thorsen NM Valentiner-Branth P, et al. Association between quadrivalent human papillomavirus vaccination and selected syndromes with autonomic dysfunction in Danish females: population based, self-controlled, case series analysis. BMJ 2020 Sep 2;370:m2930

Kharbanda EO, Vazquez-Benitez G, DeSilva MB, et al. Association of inadvertent 9-valent human papillomavirus vaccine in pregnancy with spontaneous abortion and adverse birth outcomes. JAMA Netw Open 2021 Apr 5;4(4):214340

Khoo SP, Shafii MK, Bhoo-Pathy N, et al. Prevalence and sociodemographic correlates of anogenital human papillomavirus (HPV) carriage in a cross-sectional, multi-ethnic, community-based Asian male population. PLoS One 2021 (published online Jan 20)

Kim JJ, Simms KT, Killen J, et al. Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: a cost-effectiveness analysis. PLoS Med 2021 (published online Mar 11)

Laake I, Feiring B, Jonassen CM, et al. Concurrent infection with multiple human papillomavirus types among unvaccinated and vaccinated 17-year-old Norwegian girls. J Infect Dis 2020 (published online Nov 17)

Lack A, Hiligsmann M, Bloem P, et al. Parent, provider and vaccinee preferences for HPV vaccination: a systematic review of discrete choice experiments. Vaccine 2020 Oct 27;38(46):7226-38

Lei J, Ploner A, Elfstrom KM, et al. HPV vaccination and the risk of invasive cervical cancer. N Engl J Med 2020 Oct 1;383(14):1340-8

Li AJ, Kyesi F, Mwengee W, et al. Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction. Vaccine 2021 (published online Jan 26)

Lin HY, Fu Q, Kao YH, et al. Antioxidants associated with oncogenic HPV infection in women. J Infect Dis 2021 (published online Mar 18)

Liu Y, Ang Q, Wu H, et al. Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in Beijing, China: analysis of results from China's top 3 hospital, 2009–2019. Virol J 2020 Jul 13;17:104

Mariz FC, Gray P, Bender N, et al. Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials. Lancet Infect Dis 2021 (published online May 31)

Marks DH, Katz KA. Vaccination against human papillomavirus. JAMA Dermatol 2020 (published online Aug 19)

Martin-Merion E, Castillo-Cano B, Martin-Perez M, et al. Papillomavirus vaccination and Guillain-Barre syndrome among girls: a cohort study in Spain. Vaccine 2021 (published online Jun 24)

McClung N, Burnett J, Wejnert C, et al, for the NHBS Study Group. Human papillomavirus vaccination coverage among men who have sex with men—national HIV behavioral surveillance, United States, 2017. Vaccine 2020 (published online Oct 10)

Meites E, Stone L, Amiling R, et al. Significant declines in juvenile onset recurrent respiratory papillomatosis following HPV vaccine introduction in the United States. Clin Infect Dis 2021 (published online Feb 23)

Melkonian SC, Henley SJ, Senkomago V, et al. Cancers associated with human papillomavirus in American Indian and Alaska Native populations—United States, 2013-2017. MMWR Sep 18;69(37):1283-7

Muwonge R, Basu P, Gheit T, et al. Acquisition, prevalence and clearance of type-specific human papillomavirus infections in young sexually active Indian women: a community-based multicentric cohort study. PLoS One 2020 (published online Dec 29)

Paul P, Hammer A, Rositch AF, et al. Rates of new human papillomavirus detection and loss of detection in middle-aged women by recent and past sexual behavior. J Infect Dis 2020 (published online Sep 1)

Phillips A, Hickie M, Totterdell J, et al. Adverse events following HPV vaccination: 11 years of surveillance in Australia. Vaccine 2020 (published online Jul 22)

Prabhu VS, Roberts CS, Kothari S, et al. Median age at HPV infection among women in the United States: a model-based analysis informed by real-world data. Open Forum Infect Dis 2021 (published online Mar 12)

Shiko Y, Konno R, Konishi H, et al. Effectiveness of HPV vaccination against the development of high-grade cervical lesions in young Japanese women. BMC Infect Dis 2020 Nov 5;20:808

Spencer JC, Brewer NT, Trogdon JG, et al. Cost-effectiveness of interventions to increase HPV vaccine uptake. Pediatrics 2020 Nov 1;146(5):e20200395

Szilagyi PG, Albertin CS, Gurfinkel D, et al. Prevalence and characteristics of HPV vaccine hesitancy among parents of adolescents across the US. Vaccine 2020 (published online Aug 2)

Szilagyli PG, Humiston SG, Stephens-Shields AJ, et al. Effect of training pediatric clinicians in human papillomavirus communication strategies on human papillomavirus vaccination rates: a cluster randomized clinical trial. JAMA Pediatr 2021 (published online May 24)

Tota JE, Giuliano AR, Goldstone SE, et al. Anogenital HPV infection, seroprevalence, and risk factors for HPV seropositivity among sexually active men enrolled in a global HPV vaccine trial. Clin Infect Dis 2021 (published online Jul 15)

Urbute A, Thomsen LT, Belmonte F, et al. The role of body mass index in incidence and persistence of cervical human papillomavirus infection. Ann Epidemiol 2020 (published online Jul 22)

Vaenesbranden MR, Wilk J, Sjoborg K, et al. Maternal human papillomavirus infections at mid-pregnancy and delivery in a Scandinavian mother-child cohort study. Int J Infect Dis 2021 (published online May 30)

Vahle K, Gargano JW, Lewis RM, et al. Prevalence of human papillomavirus among females older than recommended age for vaccination by birth cohort, United States 2003-2016. J Infect Dis 2021 (published online Jun 23)

Vu M, Berg CJ, Escoffery C, et al. A systematic review of practice-, provider-, and patient-level determinants impacting Asian-Americans' human papillomavirus vaccine intention and uptake. Vaccine 2020 (published online Aug 20)

Wei F, Su Y, Cui X, et al. Sequential acquisition of human papillomavirus infection at genital and anal sites, Liuzhou, China. Emerg Infect Dis 2020 Oct;26(10)

Wendland EM, Kops NL, Bessel M, et al. Effectiveness of a universal vaccination program with an HPV quadrivalent vaccine in young Brazilian women. Vaccine 2021 (published online Mar 2)

Wright JD, Chen L, Tergas AI, et al. Overuse of cervical cancer screening tests among women with average risk in the United States from 2013 to 2014. JAMA Netw Open 2021 Apr 29;4(4):e218373

Yang Y, Zhang L, Zhang Y, et al. Local hyperthermia at 44 degrees C is effective to clear cervical high-risk HPVs: a proof of concept, randomized, controlled clinical trial. Clin Infect Dis 2021 (published online Apr 27)

Yih WK, Kulldorff M, Dashevsky I, et al. A broad safety assessment of the 9-valent human papillomavirus vaccine Am J Epidemiol 2021 (published online Feb 9

Zhang J, Liu G, Cui X, et al. Human papillomavirus genotypes and the risk factors associated with multicentric intraepithelial lesions of the lower genital tract: a retrospective study. BMC Infect Dis 2021 (published online Jun 11)

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson FoundationUnorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead Become an underwriter»